Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!

▴ Insights from Recent ICMR Study Suggests So!
The implications of incomplete and deviant prescriptions extend beyond individual patient experiences to broader healthcare system challenges.

In a recent revelation by the Indian Council of Medical Research (ICMR), startling findings have emerged regarding the quality and completeness of prescriptions issued by doctors across tertiary care hospitals in India. The study, published in the Indian Journal of Medical Research (IJMR), sheds light on the prevalence of incomplete and deviant prescriptions, raising concerns about patient safety and healthcare efficacy.
 
ICMR’s Prescription Analysis: The ICMR study, titled ‘Evaluation of prescriptions from tertiary care hospitals across India for deviations from treatment guidelines & their potential consequences’, was conducted between 2019 and 2020. The survey encompassed outpatient departments of renowned government hospitals, including Delhi AIIMS and Safdarjung Hospital, under the supervision of 13 ICMR Rational Use of Medicines Centres.
 
Key Findings and Prescription Deviations: Out of a total of 7,800 patients prescriptions analysed, the study identified significant deficiencies in 2,171 prescriptions. Alarmingly, around 45% of doctors prescriptions were deemed incomplete, lacking critical details such as formulation, dose, duration, and frequency. Moreover, approximately 10% of the examined prescriptions exhibited “unacceptable deviations,” including inappropriate medication prescriptions and the assignment of more than one diagnosis.
 
Understanding Unacceptable Deviations: An “unacceptable deviation” in a prescription is characterized by its potential consequences, ranging from drug interactions and adverse drug reactions (ADRs) to increased treatment costs and antimicrobial resistance (AMR). Such deviations undermine patient safety and pose challenges to effective healthcare delivery.
 
Common Prescription Errors and Their Implications: The study highlighted several recurring prescription errors and their implications on patient health:
 
1.       Inappropriate Medications: Patients with conditions like upper respiratory tract infections (URTI) and high blood pressure received inappropriate prescriptions, contributing to potential treatment inefficacy and adverse reactions.
  
2.       Rational Use of Gastroprotective Drugs: Prescriptions lacking gastroprotective drugs in patients at risk of developing peptic ulcers pose significant risks, including abdominal bloating and potential ulcer development.
 
  
3.       Questionable Use of Specific Medications: The study flagged the unnecessary use of medications like trypsin/chymotrypsin and serratiopeptidase without sufficient scientific evidence to support their efficacy.
  
4.       Concerns with Fixed-Dose Combinations (FDCs): The co-prescription of FDCs, such as amoxicillin plus clavulanic acid, in URTIs can contribute to antimicrobial resistance (AMR) over time, compromising the effectiveness of antibiotics.
 
 
Physician Compliance with ICMR Guidelines: Despite these findings, the study noted that a majority of physicians (around 55%) adhered to disease-specific ICMR guidelines, highlighting the importance of standardized treatment protocols in optimizing patient outcomes and reducing prescription deviations.
 
Implications for Patient Care and Healthcare System: The implications of incomplete and deviant prescriptions extend beyond individual patient experiences to broader healthcare system challenges. Addressing prescription discrepancies is critical for enhancing patient safety, optimizing treatment outcomes, and mitigating the risks associated with inappropriate medication use.
 
Addressing Prescription Quality: In conclusion, the ICMR study showcased the importance of ensuring prescription quality and adherence to standardized treatment guidelines in healthcare delivery. By identifying and rectifying prescription deviations, healthcare providers can enhance patient care, minimize treatment risks, and uphold the principles of evidence-based medicine in clinical practice. The study’s findings serve as a call to action for continuous quality improvement initiatives aimed at optimizing prescription practices and promoting patient-centered care in India’s healthcare landscape.

Tags : #

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

23 Jun

Oxford University starts testing Ivermectin for treating Coronavirus

Ivermectin resulted in a reduction of virus replication in laboratory studies, the university said, adding that a small pilot showed giving the drug early could reduce viral load.

View
16 Feb

Oxford AstraZeneca vaccine granted Emergency Use Listing : WHO

As the vaccine earns approval from WHO now it is eligible for distribution in low and middle-income countries

View
13 Feb

Covaxin not finding international takers even when supplied free of cost by India

According to sources, of the 64.7 lakh Covid vaccine doses that have been sent out by India pro bono as part, only 2 lakh are doses of India’s Covaxin. The rest are doses of Serum Institute's Covishield.

View
09 Feb

Afghanistan receives 500,000 doses of AstraZeneca’s COVID-19 vaccine from India

Afghanistan has had 55,335 COVID-19 cases and 2,410 deaths from the disease, according to the health ministry.

View
08 Feb

South Africa halts AstraZeneca vaccine as study says it is ineffective against new Covid-19 strain

Jolt for AstraZeneca as the vaccine does not meet approval standard

View
09 Jan

Britain approves Moderna Covid vaccine

Britain approves 3rd Covid vaccine for use

View
05 Jan

Bangladesh approves Oxford University-AstraZeneca coronavirus vaccine

The approval to import the vaccine was granted by the Directorate General of Drug Administration (DGDA) of Bangladesh late on Monday to Beximco Pharmaceuticals Ltd. (BPL).

View
02 Jan

India approves AstraZeneca's COVID-19 vaccine

India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunization campaign in the world’s second-most populous country.

View
18 Dec

US panel set to approve Moderna vaccine

After rolling out the Pfizer coronavirus vaccine, US is now looking to approve the Moderna vaccine as well

View
11 Dec

Conflicts of interest among the UK government’s covid-19 advisers are not transparent

The BMJ’s attempts to discover more have been thwarted

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025